[
  {
    "date": "2023-12-30",
    "symbol": "ABVC",
    "period": "FY",
    "cashandcashequivalentsatcarryingvalue": 60155,
    "restrictedcash": 656625,
    "accountsreceivablenetcurrent": 1530,
    "accountsreceivablerelatedpartiesnet": 10463,
    "otherreceivablesnetcurrent": 747573,
    "shortterminvestments": 79312,
    "prepaidexpenseandotherassetscurrent": 101051,
    "assetscurrent": 1656709,
    "propertyplantandequipmentnet": 7969278,
    "operatingleaserightofuseasset": 809283,
    "longterminvestments": 2527740,
    "prepaidexpensenoncurrent": 78789,
    "securitydeposit": 62442,
    "prepaymentforlongterminvestmentsnoncurrent": 1274842,
    "otherreceivableafterallowanceforcreditlossnoncurrent": 113516,
    "assets": 14492599,
    "shorttermborrowings": 899250,
    "accruedliabilitiescurrent": 3696380,
    "contractwithcustomerliabilitycurrent": 79500,
    "taxespayablecurrent": 112946,
    "operatingleaseliabilitycurrent": 401826,
    "otherliabilitiescurrent": 173132,
    "convertiblenotespayablecurrent": 569456,
    "liabilitiescurrent": 5932490,
    "securitydepositliability": 21680,
    "operatingleaseliabilitynoncurrent": 407457,
    "liabilities": 6361627,
    "commonstockvalue": 7940,
    "additionalpaidincapital": 82636966,
    "stockholdersequitynotesubscriptionsreceivable": 451480,
    "retainedearningsaccumulateddeficit": -65420095,
    "accumulatedothercomprehensiveincomelossnetoftax": 516387,
    "treasurystockvalue": 8901668,
    "stockholdersequity": 8388050,
    "minorityinterest": -257078,
    "stockholdersequityincludingportionattributabletononcontrollinginterest": 8130972,
    "liabilitiesandstockholdersequity": 14492599,
    "preferredstockparorstatedvaluepershare": 0.001,
    "preferredstocksharesauthorized": 20000000,
    "commonstockparorstatedvaluepershare": 0.001,
    "commonstocksharesauthorized": 100000000,
    "commonstocksharesissued": 7940298,
    "commonstocksharesoutstanding": 7940298,
    "revenues": 152430,
    "costofrevenue": 302037,
    "grossprofit": -149607,
    "sellinggeneralandadministrativeexpense": 5368278,
    "researchanddevelopmentexpense": 1062916,
    "sharebasedcompensation": 1635708,
    "operatingexpenses": 8066902,
    "operatingincomeloss": -8216509,
    "investmentincomeinterest": 185481,
    "interestexpense": 2493340,
    "operatingsubleaseincome": 65900,
    "foreigncurrencytransactiongainlossbeforetax": 22690,
    "equitysecuritiesfvnirealizedgainloss": -221888,
    "othernonoperatingincomeexpense": 3384,
    "nonoperatingincomeexpense": -2437773,
    "incomelossfromcontinuingoperationsbeforeincometaxesextraordinaryitemsnoncontrollinginterest": -10654282,
    "incometaxexpensebenefit": 256006,
    "profitloss": -10910288,
    "netincomelossattributabletononcontrollinginterest": -394632,
    "netincomeloss": -10515656,
    "othercomprehensiveincomelossforeigncurrencytransactionandtranslationadjustmentnetoftax": -741,
    "comprehensiveincomenetoftax": -10516397,
    "earningspersharebasic": -2.43,
    "weightedaveragenumberofsharesoutstandingbasic": 4335650,
    "earningspersharediluted": -2.43,
    "weightedaveragenumberofdilutedsharesoutstanding": 4335650,
    "depreciation": 28531,
    "provisionfordoubtfulaccounts": 1455101,
    "othernoncashincomeexpense": -2413746,
    "deferredincometaxexpensebenefit": 115668,
    "increasedecreaseinaccountsreceivable": -228557,
    "increasedecreaseinprepaiddeferredexpenseandotherassets": -101926,
    "increasedecreaseinduefromrelatedparties": 321776,
    "commonsharesissuedfordebtconversion": 786793,
    "increasedecreaseincontractwithcustomerliability": 68515,
    "increasedecreaseinsecuritydeposits": 13700,
    "increasedecreaseinaccruedincometaxespayable": 112946,
    "increasedecreaseinduetorelatedpartiescurrent": -186860,
    "netcashprovidedbyusedinoperatingactivities": -4235845,
    "paymentstoacquirepropertyplantandequipment": 21201,
    "prepaymentforequityinvestments": 338985,
    "netcashprovidedbyusedininvestingactivities": -360186,
    "proceedsfromissuanceofcommonstock": 1050000,
    "repaymentsofshorttermdebt": 1000000,
    "proceedsfromissuanceofwarrants": 2406338,
    "proceedsfromconvertibledebt": 1462622,
    "netcashprovidedbyusedinfinancingactivities": 3918960,
    "effectofexchangerateoncashcashequivalentsrestrictedcashandrestrictedcashequivalents": 2123,
    "cashcashequivalentsrestrictedcashandrestrictedcashequivalentsperiodincreasedecreaseincludingexchangerateeffect": -674948,
    "cashcashequivalentsrestrictedcashandrestrictedcashequivalents": 716780,
    "interestpaidnet": 33180,
    "incometaxespaid": 27392,
    "purchaseofpropertyandequipmentbyissuingcommonstocktoathirdparty": 7400000,
    "stockissued1": 3306112,
    "sharesoutstanding": 7940298,
    "stockissuedduringperiodvaluenewissues": 300,
    "stockissuedduringperiodsharesnewissues": 300000,
    "stockissuedduringperiodvalueissuedforservices": 52,
    "stockissuedduringperiodsharesissuedforservices": 51941,
    "stockissuedduringperiodvaluepurchaseofassets": 370,
    "stockissuedduringperiodsharespurchaseofassets": 370000,
    "stockissuedduringperiodvalueconversionofconvertiblesecurities": 3732,
    "stockissuedduringperiodsharesconversionofconvertiblesecurities": 3732167,
    "adjustmentstoadditionalpaidincapitalwarrantissued": 1706338,
    "issuanceofprefundedwarrant": 700000,
    "stockissuedduringperiodvaluestockoptionsexercised": 200,
    "stockissuedduringperiodsharesstockoptionsexercised": 200000,
    "stockbasedcompensationforservices": 902960,
    "cumulativetransactionadjustments": -741,
    "stockissuedduringperiodvalueemployeestockownershipplan": -190628,
    "stockissuedduringperiodsharesemployeestockownershipplan": 591,
    "stockreversesplitspolicytextblock": "Stock Reverse Split",
    "concentrationofclientspolicytextblock": "Concentration of Clients",
    "constructioninprogresspolicytextblock": "Construction-in-Progress",
    "otherthantemporaryimpairmentpolicytextblock": "Other-Than-Temporary Impairment",
    "convertiblenotespayablepolicytextblock": "Convertible Notes Payable",
    "beneficialconversionfeaturepolicytextblock": "Beneficial Conversion Feature",
    "valuationofdeferredtaxassetspolicytextblock": "Valuation of Deferred Tax Assets",
    "translationadjustmentpolicytextblock": "Translation Adjustment",
    "scheduleofpropertysubjecttooravailableforcapitalleasetabletextblock": "Depreciation is calculated on the straight-line method, including propertyand equipment under capital leases, generally based on the following useful lives:",
    "scheduleofownershippercentagesofinvesteetabletextblocks": "The ownership percentages of each investee are listed as follows:",
    "scheduleofextenttheinvesteereliestabletextblock": "The extent the investee relies on the company for its business are summarized as follows:",
    "scheduleoflongterminvestmenttabletextblock": "Long-term investment mainly consists of the following:",
    "scheduleofaccountreceivableduefromrelatedpartiestabletextblock": "Accounts receivable due from related parties consistedof the following as of the periods indicated:",
    "scheduleofrevenueduefromrelatedpartytextblock": "Revenue due from related parties consisted ofthe following as of the periods indicated:",
    "scheduleofduefromrelatedpartytabletextblock": "Due from related party- Current",
    "scheduleofamountduetorelatedpartiestabletextblock": "Amount due to related parties consisted of thefollowing as of the periods indicated:",
    "propertyplantandequipmentusefullife": "P5Y",
    "propertyplantandequipmentgross": 363416,
    "accumulateddepreciationdepletionandamortizationpropertyplantandequipment": 3335041,
    "equitymethodinvestmentownershippercentage": 0.3162,
    "equitymethodinvestmentadditionalinformation": "Cost Method",
    "relatedpartytransactiondescriptionoftransaction": "No specific business relationship",
    "nonmarketablecostmethodinvestmentsnet": 7213,
    "equitymethodinvestments": 1680488,
    "assetsnoncurrent": 686206,
    "liabilitiesnoncurrent": 347193,
    "gainlossonsalesofloansnet": 734,
    "netincomelossavailabletocommonstockholdersbasic": -1194797,
    "incomelossfromequitymethodinvestments": -221888,
    "accruedresearchanddevelopmentexpense": 1799583,
    "workerscompensationliabilitycurrent": 1184505,
    "accruedroyaltiescurrent": 274028,
    "otheraccruedliabilitiescurrent": 438264,
    "accountsandotherreceivablesnetcurrent": 10463,
    "revenuefromrelatedparty": 2055,
    "otherreceivablebeforeallowanceforcreditlossnoncurrent": 839983,
    "otherreceivableallowanceforcreditlossnoncurrent": 839983,
    "currentforeigntaxexpensebenefit": 140338,
    "currentincometaxexpensebenefit": 140338,
    "deferredforeignincometaxexpensebenefit": 115668,
    "deferredincometaxesandtaxcredits": 115668,
    "deferredtaxassetsother": 713223,
    "deferredtaxassetsoperatinglosscarryforwardsforeign": 5568391,
    "operatingleaseliabilities": 213482,
    "deferredtaxassetsoperatingleaseassets": -213482,
    "deferredtaxassetsgross": 6281614,
    "deferredtaxassetsvaluationallowance": 6281614,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsoutstandingnumber": 2587104,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsoutstandingweightedaverageexerciseprice": 2.79,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsoutstandingweightedaverageremainingcontractualterm2": "P7Y8M26D",
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsexercisablenumber": 2587104,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsexercisableweightedaverageexerciseprice": 2.79,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsexercisableweightedaverageremainingcontractualterm1": "P7Y8M26D",
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsvestedandexpectedtovestoutstandingnumber": 2587104,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsvestedandexpectedtovestoutstandingweightedaverageexerciseprice": 2.79,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsvestedandexpectedtovestoutstandingweightedaverageremainingcontractualterm1": "P7Y8M26D",
    "sharebasedcompensationarrangementbysharebasedpaymentawardfairvalueassumptionsriskfreeinterestrate": 0.0279,
    "sharebasedcompensationarrangementbysharebasedpaymentawardfairvalueassumptionsexpectedterm1": "P5Y",
    "sharebasedcompensationarrangementbysharebasedpaymentawardfairvalueassumptionsexpectedvolatilityrate": 0.8386,
    "operatingleaseexpense": 358576,
    "operatingleaseleaseincomeleasepayments": 385659,
    "operatingleaseweightedaverageremainingleaseterm1": "P1Y8M23D",
    "operatingleaseweightedaveragediscountratepercent": 0.015,
    "lesseeoperatingleaseliabilitypaymentsduenexttwelvemonths": 404745,
    "lesseeoperatingleaseliabilitypaymentsdueyeartwo": 351352,
    "lesseeoperatingleaseliabilitypaymentsdueyearthree": 56916,
    "lesseeoperatingleaseliabilitypaymentsdue": 813013,
    "lesseeoperatingleaseliabilityundiscountedexcessamount": 3730,
    "operatingleaseliability": 809283,
    "businesscombinationrecognizedidentifiableassetsacquiredandliabilitiesassumedaccruedexpenseandothercurrentliabilities": 243888,
    "businesscombinationrecognizedidentifiableassetsacquiredandliabilitiesassumedcurrentliabilitieslongtermdebt": 498,
    "businesscombinationrecognizedidentifiableassetsacquiredandliabilitiesassumednet": 243386,
    "healthcareorganizationallowancefordoubtfulaccountspercentageofaccountsreceivable": 0.8724,
    "totalrevenuespercentage": 0.8004,
    "allowancefordoubtfulaccountsreceivable": 616505,
    "regulatoryassetamortizationperiod": "P18Y",
    "laborpensionfundpermonth": 0.06,
    "definedcontributionplanemployermatchingcontributionpercent": 0.06,
    "accruedemployeebenefitscurrentandnoncurrent": 13031,
    "employeebenefitsandsharebasedcompensationnoncash": 1635708,
    "definedbenefitplanfundedpercentages": 0.5,
    "relatedpartytransactiontermsandmannerofsettlement": "●",
    "percentageofpaymentsundercodevelopmentagreement": 0.5,
    "milestonepaymentsroyaltypercentage": 0.12,
    "cashequivalentsatcarryingvalue": 100000000,
    "percentageofnetsales": 0.05,
    "agreementpercentage": 0.15,
    "paymentsforparticipationliabilities": 3000000,
    "additioncashpayment": 3000000,
    "loanspayable": 1000000,
    "workingcapitalconvertibleloanpercentage": 0.05,
    "conversionofstockdescription": "The Company may convert the Note atany time into shares of Rgene’s common stock at either (i) a fixed conversion price equal to $1.00 per share or (ii) 20% discountof the stock price of the then most recent offering, whichever is lower; the conversion price is subject to adjustment as set forth inthe Note.",
    "sharesissued": 1124842,
    "saleofstockpercentageofownershipaftertransaction": 0.2,
    "deferredtaxassetspropertyplantandequipment": 37000000,
    "fairvalueofassetsacquired": 7400000,
    "commonstockcapitalsharesreservedforfutureissuance": 370000,
    "shareprice": 20,
    "percentagecommonstocksshares": 0.1868,
    "conversionofstockamountconverted1": 1895556,
    "conversionofstocksharesconverted1": 994450,
    "debtinstrumentfaceamount": 308650.58,
    "percentageofaverageamount": 0.9,
    "percentageofcashpermium": 0.05,
    "percentageofoutstandingprincipalamount": 1.2,
    "debtinstrumentincreaseaccruedinterest": 158798,
    "interestpayablecurrentandnoncurrent": 2412951,
    "accountspayableinterestbearinginterestrate": 0.01,
    "debtinstrumentinterestrateeffectivepercentage": 0.0287,
    "shorttermdebtaverageoutstandingamount": 500000,
    "depositliabilitiesaccruedinterest": 38819,
    "otherreceivables": 2667,
    "relatedpartytransactionamountsoftransaction": 147875,
    "derivativefixedinterestrate": 0.065,
    "accountsreceivablenoncurrentaccruedinterestwriteoff": 681185,
    "debtinstrumentinterestrateterms": "The development costs shall be shared 50/50 between BHK and the Company. Under the term of the agreement, BioLite issued relevant development cost to BHK.",
    "relatedpartytransactionpurchasesfromrelatedparty": 113516,
    "interestexpensedebt": 40878,
    "outstandingprincipalandaccruedinterests": 152382,
    "interestanddebtexpense": 20094,
    "investmentsoldnotyetpurchasedbalanceshares": 3732167,
    "investmentsoldnotyetpurchasedbalanceprincipalamount": 3306112,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsgrantsinperiodweightedaveragegrantdatefairvalue": 2.79,
    "lesseeoperatingleaseremainingleaseterm": "P12M",
    "lesseeoperatingleaserenewalterm": "P5Y",
    "rule10b51arradoptedflag": "false",
    "nonrule10b51arradoptedflag": "false",
    "rule10b51arrtrmntdflag": "false",
    "nonrule10b51arrtrmntdflag": "false",
    "documenttype": "10-K",
    "documentannualreport": "true",
    "documenttransitionreport": "false",
    "documentfinstmterrorcorrectionflag": "false",
    "entityinteractivedatacurrent": "Yes",
    "icfrauditorattestationflag": "false",
    "amendmentflag": "false",
    "documentperiodenddate": "2023-12-31",
    "documentfiscalyearfocus": 2023,
    "documentfiscalperiodfocus": "FY",
    "entityregistrantname": "ABVC BioPharma, Inc.",
    "entitycentralindexkey": 1173313,
    "entityfilenumber": "001-40700",
    "entitytaxidentificationnumber": "26-0014658",
    "entityincorporationstatecountrycode": "NV",
    "currentfiscalyearenddate": "--12-31",
    "entitywellknownseasonedissuer": "No",
    "entityvoluntaryfilers": "No",
    "entitycurrentreportingstatus": "Yes",
    "entityshellcompany": "false",
    "entityfilercategory": "Non-accelerated Filer",
    "entitysmallbusiness": "true",
    "entityemerginggrowthcompany": "false",
    "entityaddressaddressline1": "44370 Old Warm Springs Blvd.",
    "entityaddresscityortown": "Fremont",
    "entityaddresscountry": "CA",
    "entityaddresspostalzipcode": 94538,
    "cityareacode": "(510)",
    "localphonenumber": "-668-0881",
    "security12btitle": "Common Stock, par value $0.001 per share",
    "tradingsymbol": "ABVC",
    "securityexchangename": "NASDAQ",
    "auditorname": "WWC, P.C.",
    "auditorfirmid": 1171,
    "auditorlocation": "San Mateo, California"
  },
  {
    "date": "2022-12-30",
    "symbol": "ABVC",
    "period": "FY",
    "cashandcashequivalentsatcarryingvalue": 85265,
    "restrictedcashandcashequivalentsatcarryingvalue": 1306463,
    "accountsreceivablenetcurrent": 98325,
    "accountsreceivablerelatedpartiescurrent": 757343,
    "prepaymentforlongterminvestments": 513819,
    "shortterminvestments": 75797,
    "prepaidexpenseandotherassetscurrent": 150235,
    "assetscurrent": 68302,
    "propertyplantandequipmentnet": 573978,
    "operatingleaserightofuseasset": 1161141,
    "longterminvestments": 842070,
    "deferredincometaxassetsnet": 117110,
    "prepaidexpensenoncurrent": 135135,
    "securitydeposit": 58838,
    "prepaymentforlongterminvestmentsnoncurrent": 2838578,
    "duefromrelatedpartiesnoncurrent": 1141378,
    "assets": 9855475,
    "shorttermbankloansandnotespayable": 1893750,
    "accruedliabilitiescurrent": 2909587,
    "advancefromcustomers": 10985,
    "operatingleaseliabilitycurrent": 369314,
    "duetorelatedpartiescurrent": 635893,
    "liabilitiescurrent": 2478868,
    "securitydepositliability": 7980,
    "operatingleaseliabilitynoncurrent": 791827,
    "liabilities": 6619336,
    "commonstockvalue": 32857,
    "additionalpaidincapital": 67907479,
    "stockholdersequitynotesubscriptionsreceivable": 1354440,
    "retainedearningsaccumulateddeficit": -54904439,
    "accumulatedothercomprehensiveincomelossdefinedbenefitpensionandotherpostretirementplansnetoftax": -517128,
    "treasurystockvalue": 9100000,
    "stockholdersequity": 3098585,
    "minorityinterest": 137554,
    "stockholdersequityincludingportionattributabletononcontrollinginterest": 137554,
    "liabilitiesandstockholdersequity": 9855475,
    "preferredstockparorstatedvaluepershare": 0.001,
    "preferredstocksharesauthorized": 20000000,
    "commonstockparorstatedvaluepershare": 0.001,
    "commonstocksharesauthorized": 100000000,
    "commonstocksharesissued": 32857329,
    "commonstocksharesoutstanding": 32857329,
    "revenues": 969783,
    "costofrevenue": 286415,
    "grossprofit": 8239,
    "sellinggeneralandadministrativeexpense": 6067545,
    "researchanddevelopmentexpense": 2693457,
    "allocatedsharebasedcompensationexpense": 7036778,
    "operatingexpenses": 15797780,
    "operatingincomeloss": -15114412,
    "investmentincomeinterest": 187817,
    "interestexpense": 293968,
    "rentincome": 107150,
    "goodwillimpairmentloss": 110125,
    "realizedinvestmentgainslosses": -7446,
    "foreigncurrencytransactiongainlossbeforetax": -259463,
    "otherincome": -24149,
    "othernonoperatingincomeexpense": -400184,
    "incomelossfromcontinuingoperationsbeforeincometaxesextraordinaryitemsnoncontrollinginterest": -15514596,
    "incometaxexpensebenefit": 797778,
    "profitloss": 110865,
    "netincomelossattributabletononcontrollinginterest": 110865,
    "netincomeloss": -16423239,
    "othercomprehensiveincomelossforeigncurrencytransactionandtranslationadjustmentnetoftax": -22532,
    "comprehensiveincomenetoftax": -16445771,
    "earningspersharebasic": -0.52,
    "weightedaveragenumberofsharesoutstandingbasic": 31664660,
    "earningspersharediluted": -0.5,
    "weightedaveragenumberofdilutedsharesoutstanding": 30153484,
    "depreciation": 23799,
    "sharebasedcompensation": 7036778,
    "increasedecreaseininventoryallowanceforvaluationlosses": -25975,
    "provisionfordoubtfulaccount": -184589,
    "othernoncashincomeexpense": -32350,
    "investmentloss": 110125,
    "deferredincometaxexpensebenefit": 864802,
    "increasedecreaseinaccountsreceivable": 614166,
    "increasedecreaseinsecuritydeposits": 238092,
    "increasedecreaseinduefromrelatedparties": 837014,
    "increasedecreaseinaccruedliabilitiesandotheroperatingliabilities": 1608784,
    "increasedecreaseinsecuritydepositreceived": 2600,
    "increasedecreaseinduetorelatedparties": 242469,
    "netcashprovidedbyusedinoperatingactivities": -7398391,
    "paymentstoacquirepropertyplantandequipment": 119692,
    "paymentstoacquirelongterminvestments": 1601992,
    "netcashprovidedbyusedininvestingactivities": -1721684,
    "proceedsfromissuanceofcommonstock": 3663925,
    "proceedsfromshorttermdebt": 350000,
    "netcashprovidedbyusedinfinancingactivities": 4013925,
    "effectofexchangerateoncashcashequivalentsrestrictedcashandrestrictedcashequivalents": -67337,
    "cashcashequivalentsrestrictedcashandrestrictedcashequivalentsperiodincreasedecreaseincludingexchangerateeffect": -5173487,
    "cashcashequivalentsrestrictedcashandrestrictedcashequivalents": 1391728,
    "interestpaidnet": 285465,
    "incometaxespaid": 1600,
    "sharesoutstanding": -275347,
    "stockissuedduringperiodvaluenewissues": 3663925,
    "stockissuedduringperiodsharesnewissues": 2000000,
    "stockissuedduringperiodvalueissuedforservices": 4891888,
    "stockissuedduringperiodsharesissuedforservices": 1931007,
    "stockissuedduringperiodvaluesharebasedcompensation": 902960,
    "stockissuedduringperiodvaluerestrictedstockawardgross": 1241930000000,
    "cumulativetransactionadjustments": -22532,
    "longterminvestmenttextblock": "6. LONG-TERM INVESTMENTS  ",
    "convertiblenotespayabledisclosuretextblock": "7. CONVERTIBLE NOTES PAYABLE ",
    "paycheckprotectionprogramloanpayabletextblock": "9. PAYCHECK PROTECTION PROGRAM LOAN PAYABLE  ",
    "stockoptionstextblock": "15. STOCK OPTIONS ",
    "forwardstocksplitspolicytextblock": "Forward Stock Split ",
    "stockreversesplitpolicytextblock": "Stock Reverse Split ",
    "concentrationofclientspolicytextblock": "Concentrationof clients ",
    "longtermequityinvestmentpolicy": "Long-term Equity Investment  ",
    "otherthantemporaryimpairmentpolicytextblock": "Other-Than-Temporary Impairment ",
    "beneficialconversionfeature": "Beneficial Conversion Feature ",
    "valuationofdeferredtaxassetspolicytextblock": "Valuation of Deferred Tax Assets ",
    "translationadjustmentpolicytextblock": "Translation Adjustment ",
    "scheduleofpropertyandequipmentestimatedusefullifetabletextblock": "                Estimated Life    in Years      Buildings and leasehold    improvements         5 ~ 50      Machinery and equipment         5 ~ 10      Office equipment         3 ~ 6   ",
    "scheduleofaccountreceivableduefromrelatedpartiestabletextblock": "            December 31,      December 31,             2022      2021       GenePharm Inc.     $142,225      $142,225       Rgene      615,118       2,374       Amkey      -       800       Total     $757,343      $145,399    ",
    "scheduleofrelatedpartytransactionsamountduetorelatedparty": "            December 31,      December 31,             2022      2021       BioFirst Corporation     $188,753      $40,878       BioFirst (Australia)      275,901       132,443       AsiaGene      -       24,017       YuanGene      -       9,205       The Jiangs      19,789       18,750       Due to shareholders      151,450       168,131                              Total     $635,893      $393,424    ",
    "scheduleofoperatingleasearrangementstabletextblock": "            December 31, 2022      December 31, 2021       ASSETS                    Operating lease right-of-use assets     $1,161,141      $1,471,899       LIABILITIES                      Operating lease liabilities (current)      369,314       347,100       Operating lease liabilities (noncurrent)      791,827       1,124,799    ",
    "scheduleofminimumfutureannualpaymentsundernoncancellableleasestabletextblock": "            Operating leases       2023     $374,478       2024      389,613       2025      348,837       2026      56,916       2027      -       Total future minimum lease payments, undiscounted      1,169,844       Less: Imputed interest      8,703       Present value of future minimum lease payments     $1,161,141   ",
    "propertyplantandequipmentusefullife": 6,
    "propertyplantandequipmentgross": 3878435,
    "accumulateddepreciationdepletionandamortizationpropertyplantandequipment": 3304457,
    "propertyplantandequipmentothernet": 573978,
    "ownershippercentage": 0.01,
    "relatedpartytransactiondescriptionoftransactions": "An entity 100% owned by Mr. Tsung-Shann Jiang",
    "nonmarketablecostmethodinvestmentsnet": 842070,
    "equitymethodinvestments": 842070,
    "assetsnoncurrent": 303893,
    "liabilitiesnoncurrent": 2441,
    "stockholdersequityother": -2481309,
    "gainlossonsalesofloansnet": 30162,
    "netincomelossavailabletocommonstockholdersbasic": -16423239,
    "shorttermborrowings": 1893750,
    "accountsreceivablerelatedparties": 757343,
    "rgene": 904043,
    "revenuefromrelatedpartytotal": 904043,
    "duefromrelatedpartiesnoncurrents": 1141378,
    "duetorelatedpartycurrentandnoncurrent": 635893,
    "currentstateandlocaltaxexpensebenefit": 2400,
    "currentincometaxexpensebenefit": 2400,
    "deferredforeignincometaxexpensebenefit": 795378,
    "deferredincometaxesandtaxcredits": 795378,
    "totalprovisionforincometaxe": -797778,
    "assetimpairmentcharges": 709961,
    "deferredtaxassetsoperatinglosscarryforwardsforeign": 5866623,
    "operatingleaseliability": 213482,
    "otherassetsmiscellaneousnoncurrent": 213482,
    "otherdeferredcostsgross": 6576584,
    "deferredtaxassetsvaluationallowance": 6459474,
    "deferredtaxassetsliabilitiesnet": 117110,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsoutstandingnumber": 761920,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsoutstandingweightedaverageexerciseprice": 2.79,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsexercisablenumber": 2587104,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsexercisableweightedaverageexerciseprice": 2.79,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsgrantweightedaverageremainingcontractualterm": 8.74,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsvestedandexpectedtovestoutstandingnumber": 2587104,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsvestedandexpectedtovestoutstandingweightedaverageexerciseprice": 2.79,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsgrantweightedaverageremainingcontractualterm1": 8.74,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsgrantsinperiod": 761920,
    "sharebasedcompensationarrangementsbysharebasedpaymentawardoptionsgrantsinperiodweightedaverageexerciseprice": 3,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsoutstandingweightedaverageremainingcontractualterm2": 8.74,
    "sharebasedcompensationarrangementbysharebasedpaymentawardfairvalueassumptionsriskfreeinterestrate": 0.0279,
    "sharebasedcompensationarrangementbysharebasedpaymentawardfairvalueassumptionsexpectedterm1": 5,
    "sharebasedcompensationarrangementbysharebasedpaymentawardfairvalueassumptionsexpectedvolatilityrate": 0.8386,
    "weightedaveragesharesoutstandingbasic": 31664600,
    "weightedaveragenumberofsharesdiluted": 31664600,
    "losspersharebasic": -0.52,
    "losspersharediluted": -0.52,
    "operatingleaserightofuseassetamortizationexpense": 1161141,
    "operatingleaseliabilitiescurrents": 369314,
    "operatingleaseliabilitienoncurrent": 791827,
    "operatingleaseexpense": 358576,
    "operatingleaseleaseincomeleasepayments": 358576,
    "operatingleaseweightedaverageremainingleaseterm1": 2.48,
    "operatingleaseweightedaveragediscountratepercent": 0.0149,
    "operatingleasesfutureminimumpaymentdueintwoyears": 374478,
    "operatingleasesfutureminimumpaymentdueinthreeyears": 389613,
    "operatingleasesfutureminimumpaymentdueinfouryears": 348837,
    "operatingleasesfutureminimumpaymentdueinfiveyears": 56916,
    "operatingleasesfutureminimumpaymentdue": 1169844,
    "interestportionofminimumleasepaymentssaleleasebacktransaction": 8703,
    "presentvalueoffutureminimumleasepaymentsaleleasebacktransactions": 1161141,
    "excessstocksharesissued": 205519223,
    "commonstockissuedbeforestocksplit": 65431144,
    "percentageofcommonsharesissuedandoutstanding": 0.797,
    "percentageofissuedsharecapital": 1,
    "stockholdersequitynotestocksplit": "Pursuant to the Merger, all of the issued andoutstanding common shares of BriVision were converted, at an exchange ratio of 0.2536-for-1, into an aggregate of 166,273,921 (52,936,583pre-stock split) common shares of the Company and BriVision had become a wholly owned subsidiary of the Company.",
    "companyreported": 16312374,
    "capital": 2832282,
    "restrictedcashandcashequivalents": 1306463,
    "healthcareorganizationallowancefordoubtfulaccountspercentageofaccountsreceivable": 0.16620000000000001,
    "totalrevenues": 0.9322,
    "labourpensionfundpercentage": 0.06,
    "percentageofmonthlycontributions": 0.06,
    "definedbenefitplanservicecost": 13031,
    "stockbasedcompensationforemployees": 1241930,
    "stockbasedcompensationfornonemployees": 5794848,
    "definedbenefitplanfundedpercentages": 0.5,
    "percentageofpaymentsundercodevelopmentagreement": 0.5,
    "milestonepaymentsroyaltypercentage": 0.12,
    "collaborativeagreementsdescription": "In addition to the total of NT$50 million, approximatelyequivalent to $1.60 million, BioLite Taiwan is entitled to receive 50% of the future net licensing income or net sales profit.",
    "paymentsforparticipationliabilities": 3000000,
    "depreciationdepletionandamortization": 23799,
    "landandlandimprovements": 361193,
    "variableinterestentityownershippercentage": 0.2177,
    "sharebasedcompensationarrangementbysharebasedpaymentawardpurchasepriceofcommonstockpercent": 0.28850000000000003,
    "interestanddebtexpense": 208657,
    "debtinstrumentmaturitydate": "November 30, 2022",
    "debtinstrumentinterestrateeffectivepercentage": 0.0267,
    "interestexpensedebt": 46957,
    "loanspayable": 1000000,
    "debtinstrumentpaymentterms": "The loan was granted pursuant to a promissorynote dated April 14, 2020 issued by the Company, which matures on April 13, 2022 and bears interest at a rate of 1.00% per annum.",
    "interestrate": 0.136224,
    "debtinstrumentconvertiblethresholdpercentageofstockpricetrigger": 0.12,
    "shorttermdebtaverageoutstandingamount": 188753,
    "accountsreceivablenoncurrentaccruedinterestwriteoff": 40878,
    "duefromemployeesnoncurrent": 112822,
    "outstandingadvancefromrelatedparty": 19789,
    "aggregateworkingcapital": 275901,
    "outstandingprincipalandaccruedinterest": 151450,
    "interestexpenserelatedparty": 21378,
    "fairvalueofoptionsgranted": 1.63,
    "sharebasedcompensationarrangementbysharebasedpaymentawardnumberofsharesavailableforgrant": 3860211,
    "employeeservicesharebasedcompensationtaxbenefitfromexerciseofstockoptions": 1241930,
    "entityregistrantname": "ABVC BioPharma, Inc.",
    "tradingsymbol": "ABVC",
    "documenttype": "10-K",
    "currentfiscalyearenddate": "December 31",
    "amendmentflag": "false",
    "entitycentralindexkey": 1173313,
    "entitycurrentreportingstatus": "Yes",
    "entityvoluntaryfilers": "No",
    "entityfilercategory": "Non-accelerated filer",
    "entitywellknownseasonedissuer": "No",
    "documentperiodenddate": "December 31, 2022",
    "documentfiscalyearfocus": 2022,
    "documentfiscalperiodfocus": "FY",
    "entitysmallbusiness": "true",
    "entityemerginggrowthcompany": "false",
    "entityshellcompany": "true",
    "icfrauditorattestationflag": "false",
    "documentannualreport": "true",
    "documenttransitionreport": "false",
    "entityfilenumber": "001-40700",
    "entityincorporationstatecountrycode": "Nevada",
    "entitytaxidentificationnumber": "26-0014658",
    "entityaddressaddressline1": "44370 Old Warm Springs Blvd",
    "entityaddresscityortown": "Fremont",
    "entityaddresscountry": "CA",
    "entityaddresspostalzipcode": 94538,
    "cityareacode": 510,
    "localphonenumber": "-668-0881",
    "security12btitle": "Common Stock, par value $0.001 per share",
    "securityexchangename": "Nasdaq",
    "entityinteractivedatacurrent": "Yes",
    "auditorname": "WWC, P.C.",
    "auditorfirmid": 1171,
    "auditorlocation": "San Mateo, California"
  },
  {
    "date": "2021-12-30",
    "symbol": "ABVC",
    "period": "FY",
    "cashandcashequivalentsatcarryingvalue": 5828548,
    "restrictedcashandcashequivalentsatcarryingvalue": 736667,
    "accountsreceivablenetcurrent": 280692,
    "accountsreceivablerelatedpartiescurrent": 145399,
    "duefromotherrelatedpartiescurrent": 1286618,
    "inventorynet": 25975,
    "shortterminvestments": 108147,
    "prepaymentforlongterminvestments": 684720,
    "prepaidexpenseandotherassetscurrent": 528354,
    "assetscurrent": 9625120,
    "propertyplantandequipmentnet": 525881,
    "operatingleaserightofuseasset": 1471899,
    "longterminvestments": 932755,
    "deferredincometaxassetsnet": 981912,
    "prepaidexpensenoncurrent": 119309,
    "securitydeposit": 41157,
    "assets": 13698033,
    "shorttermbankloansandnotespayable": 1640000,
    "accruedliabilitiescurrent": 1300803,
    "advancefromcustomers": 10985,
    "operatingleaseliabilitycurrent": 347100,
    "duetorelatedpartiescurrent": 18750,
    "liabilitiescurrent": 3692312,
    "loanspayable": 650000,
    "securitydepositliability": 10580,
    "operatingleaseliabilitynoncurrent": 32522,
    "liabilities": 4827691,
    "commonstockvalue": 28926,
    "additionalpaidincapital": 58113667,
    "stockholdersequitynotesubscriptionsreceivable": 2257400,
    "retainedearningsaccumulateddeficit": -38481200,
    "accumulatedothercomprehensiveincomelossnetoftax": 539660,
    "treasurystockvalue": 9100000,
    "stockholdersequity": 8843653,
    "minorityinterest": 26689,
    "stockholdersequityincludingportionattributabletononcontrollinginterest": 26689,
    "liabilitiesandstockholdersequity": 13698033,
    "preferredstockparorstatedvaluepershare": 0.001,
    "preferredstocksharesauthorized": 20000000,
    "commonstockparorstatedvaluepershare": 0.001,
    "commonstocksharesauthorized": 100000000,
    "commonstocksharesissued": 28926322,
    "commonstocksharesoutstanding": 28926322,
    "revenues": 26693,
    "costofrevenue": 5086,
    "grossprofit": 8348,
    "sellinggeneralandadministrativeexpense": 5746119,
    "researchanddevelopmentexpense": 1003805,
    "sharebasedcompensation": 5306755,
    "operatingexpenses": 12056679,
    "operatingincomeloss": -11705968,
    "interestincomes": 43196,
    "interestexpense": 227210,
    "rentalincomenonoperating": 134576,
    "operatingsubleaseincomerelatedparties": 4800,
    "foreigncurrencytransactiongainlossbeforetax": 426316,
    "equitysecuritiesfvnirealizedgainloss": -269844,
    "othernonoperatingincomeexpense": 22409,
    "governmentgrantincome": 360898,
    "nonoperatingincomeexpense": 495141,
    "incomelossfromcontinuingoperationsbeforeincometaxesextraordinaryitemsnoncontrollinginterest": -11210827,
    "incometaxexpensebenefit": 825024,
    "profitloss": -12035851,
    "incomelossfromcontinuingoperationsattributabletononcontrollingentity": 802962,
    "netlossattributabletoabvcandsubsidiaries": -12838813,
    "othercomprehensiveincomelossforeigncurrencytransactionandtranslationadjustmentnetoftax": -25200,
    "comprehensiveincomenetoftax": -12864013,
    "earningspersharebasicanddiluted": -0.51,
    "weightedaveragenumberofshareoutstandingbasicanddiluted": 25053522,
    "netincomeloss": -12035851,
    "depreciation": 11993,
    "allocatedsharebasedcompensationexpense": 5306755,
    "unrealizedgainlossoninvestments": -269844,
    "deferredincometaxexpensebenefit": 824199,
    "increasedecreaseinaccountsreceivable": 120980,
    "increasedecreaseinaccountsreceivableandotheroperatingassets": 357276,
    "increasedecreaseduefromotherrelatedparties": 595037,
    "increasedecreaseininventories": 25830,
    "increasedecreaseinnotespayablecurrent": -23044,
    "increasedecreaseinaccruedliabilitiesandotheroperatingliabilities": -173151,
    "increasedecreaseinothernoncurrentliabilities": -1085,
    "increasedecreaseinduetorelatedparties": -317358,
    "netcashprovidedbyusedinoperatingactivities": -7597719,
    "paymentstoacquireinvestments": 107547,
    "paymentstoacquirepropertyplantandequipment": 17503,
    "paymentstoacquirelongterminvestments": 680916,
    "netcashprovidedbyusedininvestingactivities": -805966,
    "issuanceofcommonsharesforstockbasedcompensation": 11119452,
    "paymentsofstockissuancecosts": 850429,
    "repaymentsofconvertibledebt": 306836,
    "repaymentsofsubordinatedshorttermdebt": 100000,
    "repaymentsofnotespayable": 107400,
    "proceedsfromissuanceofotherlongtermdebt": 236498,
    "netproceedsfromshorttermborrowingsfromthirdparties": 4265,
    "netcashprovidedbyusedinfinancingactivities": 9995550,
    "effectofexchangerateoncashandcashequivalents": -28021,
    "cashcashequivalentsrestrictedcashandrestrictedcashequivalentsperiodincreasedecreaseincludingexchangerateeffect": 1563844,
    "cashcashequivalentsrestrictedcashandrestrictedcashequivalents": 6565215,
    "interestpaidnet": 333873,
    "debtconversionconvertedinstrumentamount1": 2693548,
    "sharesoutstanding": -275347,
    "adjustmentstoadditionalpaidincapitalsharebasedcompensationstockoptionsrequisiteserviceperiodrecognition": 2675205,
    "stockissuedduringperiodvaluenewissues": 10269023,
    "stockissuedduringperiodsharesnewissues": 3027750,
    "stockissuedduringperiodvalueissuedforservices": 1728590,
    "stockissuedduringperiodsharesissuedforservices": 366934,
    "stockissuedduringperiodvalueconversionofunits": 2693548,
    "stockissuedduringperiodsharesconversionofunits": 1111112,
    "stockissuedduringperiodvaluesharebasedcompensationservices": 902960,
    "netincomelossattributabletononcontrollinginterest": -12035851,
    "cumulativetransactionadjustments": -25200,
    "longterminvestmenttextblock": "6.LONG-TERM INVESTMENTS  ",
    "convertiblenotespayabledisclosuretextblock": "7.CONVERTIBLE NOTES PAYABLE ",
    "bankloanstextblock": "8.BANK LOANS ",
    "paycheckprotectionprogramloanpayabletextblock": "9.PAYCHECK PROTECTION PROGRAM LOAN PAYABLE  ",
    "stockoptionstextblock": "14.STOCK OPTIONS ",
    "operatingleasesoflesseedisclosurestextblock": "16.LEASE ",
    "forwardstocksplitspolicytextblock": "ForwardStock Split ",
    "stockreversesplitpolicytextblock": "StockReverse Split ",
    "longtermequityinvestmentpolicy": "Long-termEquity Investment  ",
    "otherthantemporaryimpairmentpolicytextblock": "Other-Than-TemporaryImpairment ",
    "beneficialconversionfeature": "BeneficialConversion Feature ",
    "valuationofdeferredtaxassetspolicytextblock": "Valuationof Deferred Tax Assets ",
    "translationadjustmentpolicytextblock": "TranslationAdjustment ",
    "scheduleofpropertyandequipmentestimatedusefullifetabletextblock": "                Estimated Life    in Years      Buildings and leasehold    improvements         5 ~ 50      Machinery and equipment         5 ~ 10      Office equipment         3 ~ 6   ",
    "scheduleofaccountreceivableduefromrelatedpartiestabletextblock": "            December 31,      December 31,             2021      2020       GenePharm Inc.     $142,225      $142,225       Rgene      2,374       -       Amkey      800       1,210       Total     $145,399      $143,435    ",
    "scheduleofrelatedpartytransactionsamountduetorelatedparty": "            December 31,      December 31,             2021      2020       BioFirst Corporation     $40,878      $23,647       BioFirst (Australia)      132,443       -       AsiaGene      24,017       -       YuanGene      9,205       9,205       The Jiangs      18,750       16,627       Due to shareholders      168,131       166,261       Due to employee      -       72,705       Total     $393,424      $288,445    ",
    "scheduleofoperatingleasearrangementstabletextblock": "                December 31,    2021              December 31,    2020           ASSETS                                    Operating lease right-of-use assets         $    1,471,899              $    1,772,747           LIABILITIES                                              Operating lease liabilities (current)              347,100                   316,178           Operating lease liabilities (noncurrent)              1,124,799                   1,456,567        ",
    "scheduleoffutureminimumrentalpaymentforoperatingleasestabletextblock": "            Operating    leases       2022     $353,896       2023      360,994       2024      375,938       2025      338,676       Thereafter      56,916       Total future minimum lease payments, undiscounted      1,486,420       Less: Imputed interest      14,521       Present value of future    minimum lease payments     $1,471,899   ",
    "propertyplantandequipmentusefullife": 6,
    "inventoryfinishedgoods": 96725,
    "inventoryrawmaterials": 84620,
    "allowanceforinventoryvaluationandobsolescenceloss": -155370,
    "propertyplantandequipmentgross": 3840352,
    "accumulateddepreciationdepletionandamortizationpropertyplantandequipment": 3314471,
    "equitymethodinvestmentownershippercentage": 0.015,
    "accountingtreatmentdescription": "Equity Method",
    "relatedpartytransactiondescriptionoftransactions": "Entity controlled by controlling beneficiary shareholder of ABVC",
    "nonmarketablecostmethodinvestmentsnet": 932755,
    "equitymethodinvestments": 932755,
    "otherassetscurrent": 73452,
    "otherassetsnoncurrent": 374423,
    "otherliabilitiescurrent": 1934786,
    "stockholdersequityother": -1486911,
    "longterminvestmentnetloss": -576514,
    "gainlossoninvestments": -269844,
    "shareofequitymethodinvesteelosses": -269844,
    "shorttermborrowings": 1640000,
    "accountsreceivablerelatedparties": 145399,
    "duefromtherelatedpartiescurrent": 1286618,
    "duetorelatedpartycurrentandnoncurrent": 393424,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsoutstandingnumber": 545182,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsoutstandingweightedaverageexerciseprice": 2.7,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsgrantsinperiod": 1280002,
    "sharebasedcompensationarrangementsbysharebasedpaymentawardoptionsgrantsinperiodweightedaverageexerciseprice": 3,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsoutstandingweightedaverageremainingcontractualterm2": 9.51,
    "sharebasedcompensationarrangementbysharebasedpaymentawardequityinstrumentsotherthanoptionsnonvestedweightedaveragegrantdatefairvalue": 616056,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsexercisablenumber": 1825184,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsexercisableweightedaverageexerciseprice": 2.7,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsgrantweightedaverageremainingcontractualterm": 9.51,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsexercisableintrinsicvalue1": 616056,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsvestedandexpectedtovestoutstandingnumber": 1825184,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsvestedandexpectedtovestoutstandingweightedaverageexerciseprice": 2.7,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsgrantweightedaverageremainingcontractualterm1": 9.51,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsvestedandexpectedtovestexercisableaggregateintrinsicvalue": 616056,
    "sharebasedcompensationarrangementbysharebasedpaymentawardfairvalueassumptionsriskfreeinterestrate": 0.0113,
    "sharebasedcompensationarrangementbysharebasedpaymentawardfairvalueassumptionsexpectedterm1": 5,
    "sharebasedcompensationarrangementbysharebasedpaymentawardfairvalueassumptionsexpectedvolatilityrate": 1.0851000000000002,
    "netincomelossavailabletocommonstockholdersbasic": -12838813,
    "weightedaveragenumberofsharesoutstandingbasic": 25053522,
    "weightedaveragenumberofdilutedsharesoutstanding": 25053522,
    "earningspersharebasic": -0.51,
    "earningspersharediluted": -0.51,
    "operatingleaseliability": 347100,
    "operatingleaseliabilitienoncurrent": 1124799,
    "operatingleasecost": 335208,
    "operatingleaseleaseincomeleasepayments": 335208,
    "operatingleaseweightedaverageremainingleaseterm1": 2.9,
    "operatingleaseweightedaveragediscountratepercent": 0.0139,
    "operatingleasesfutureminimumpaymentduecurrent": 353896,
    "operatingleasesfutureminimumpaymentdueintwoyears": 360994,
    "operatingleasesfutureminimumpaymentdueinthreeyears": 375938,
    "operatingleasesfutureminimumpaymentdueinfouryears": 338676,
    "operatingleasesfutureminimumpaymentduethereafter": 56916,
    "operatingleasesfutureminimumpaymentdue": 1486420,
    "interestportionofminimumleasepaymentssaleleasebacktransaction": 14521,
    "presentvalueoffutureminimumleasepaymentsaleleasebacktransactions": 1471899,
    "cash": 5828548,
    "restrictedcashandcashequivalents": 736667,
    "percentageofmonthlycontribution": 0.06,
    "employeebenefitsandsharebasedcompensationnoncash": 11375,
    "employeebenefitsandsharebasedcompensation": 2675205,
    "stockbasedcompensationfornonemployees": 2631550,
    "percentageofpaymentsundercodevelopmentagreement": 0.5,
    "issuanceofstockvalue": 3000000,
    "milestonepaymentsroyaltypercentage": 0.12,
    "collaborativeagreementsdescription": "Inaddition to the total of NT$50 million, approximately equivalent to $1.60 million, BioLite Taiwan is entitled to receive 50% of the futurenet licensing income or net sales profit.",
    "paymentsforparticipationliabilities": 3000000,
    "otherdepreciationandamortization": 11993,
    "debtinstrumentconvertiblethresholdpercentageofstockpricetrigger": 0.31620000000000004,
    "purchaseadditionalshares": 317000,
    "totalinterestexpenses": 193548,
    "debtinstrumentinterestrateeffectivepercentage": 0.0168,
    "interestanddebtexpense": 18143,
    "regularinterestratedescription": "On March 31, 2020, the Company extended the Loan Agreement with the same term for seven months, which is due on October31, 2020.",
    "loanfrompaycheckprotectionprogram": 132331,
    "forgivenamountpercentageusedforpayroll": 0.6,
    "debtinstrumentinterestratestatedpercentage": 0.01,
    "interestexpenseother": 8592,
    "debtinstrumentaggregateamount": 49110,
    "stockpurchaseagreementdescription": "Under the terms of the loan agreement, the loan bears interest at 1% per month (or equivalent to 12% per annum) and the maturity date was December 31, 2020.",
    "shorttermdebtaverageoutstandingamount": 1610,
    "accruedinterest": 168131,
    "duefromrelatedpartiescurrent": 1889,
    "debtinstrumentinterestrateterms": "the Company and BioFirst entered into loan agreements for a total amount of $45,000, $140,000, and $280,000, respectively, to meet its working capital needs. The loan will be matured on November 1, 2022, November 11, 2022, and December 19, 2022, respectively, all with an interest rate of 6.5% per annum.",
    "duefromotherrelatedparties": 124972,
    "outstandingadvancefromrelatedparty": 150000,
    "aggregateworkingcapital": 9205,
    "interestexpenserelatedparty": 22779,
    "professionalfees": 4514800,
    "stocksubscriptionreceivable": 2257400,
    "aggregatecommonstockshares": 915856,
    "debtinstrumentconvertibletermsofconversionfeature": "a.",
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsvestedweightedaveragegrantdatefairvalue": 2.09,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsgrants": "$2,675,205",
    "termsofagreementdescription": "In accordance with the terms of the Agreement, the Company shall pay BioLite (i) milestone payments of up to $100 millionin cash and equity of the Company or equity securities owned by it at various stages on a schedule dictated by BioLite’s achievementsof certain milestones, as set forth in the Agreement (the “Milestone Payments”) and (ii) a royalty payment equal to 5% ofnet sales of the drug products when ABV-1501 is approved for sale in the licensed territories.",
    "entityregistrantname": "ABVCBioPharma, Inc.",
    "tradingsymbol": "ABVC",
    "documenttype": "10-K",
    "currentfiscalyearenddate": "December 31",
    "amendmentflag": "false",
    "entitycentralindexkey": 1173313,
    "entitycurrentreportingstatus": "Yes",
    "entityvoluntaryfilers": "No",
    "entityfilercategory": "Non-accelerated filer",
    "entitywellknownseasonedissuer": "No",
    "documentperiodenddate": "December 31, 2021",
    "documentfiscalyearfocus": 2021,
    "documentfiscalperiodfocus": "FY",
    "entitysmallbusiness": "true",
    "entityemerginggrowthcompany": "false",
    "entityshellcompany": "true",
    "icfrauditorattestationflag": "false",
    "documentannualreport": "true",
    "documenttransitionreport": "false",
    "entityfilenumber": "333-91436",
    "entityincorporationstatecountrycode": "Nevada",
    "entitytaxidentificationnumber": "26-0014658",
    "entityaddressaddressline1": "44370Old Warm Springs Blvd",
    "entityaddresscityortown": "Fremont",
    "entityaddresscountry": "CA",
    "entityaddresspostalzipcode": 94538,
    "cityareacode": "(510)",
    "localphonenumber": "-668-0881",
    "security12btitle": "Common Stock, par value $0.001 per share",
    "securityexchangename": "The Nasdaq Stock Market LLC",
    "entityinteractivedatacurrent": "Yes",
    "auditorfirmid": 2851,
    "auditorname": "KCCW Accountancy Corp.",
    "auditorlocation": "DiamondBar, California"
  },
  {
    "date": "2020-12-30",
    "symbol": "ABVC",
    "period": "FY",
    "entityregistrantname": "American BriVision (Holding) Corp",
    "entitycentralindexkey": 1173313,
    "amendmentflag": "false",
    "currentfiscalyearenddate": "--12-31",
    "documenttype": "10-K",
    "documentperiodenddate": "2020-12-31",
    "documentfiscalperiodfocus": "FY",
    "documentfiscalyearfocus": 2020,
    "entityfilercategory": "Non-accelerated Filer",
    "entitysmallbusiness": "true",
    "entityshellcompany": "false",
    "entitycurrentreportingstatus": "Yes",
    "entityemerginggrowthcompany": "false",
    "entityfilenumber": "333-91436",
    "entityinteractivedatacurrent": "Yes",
    "entityincorporationstatecountrycode": "NV",
    "entitywellknownseasonedissuer": "No",
    "entityvoluntaryfilers": "No",
    "cashandcashequivalentsatcarryingvalue": 4273208,
    "restrictedcashandcashequivalents": 728163,
    "accountsreceivablenet": 159712,
    "accountsreceivablerelatedpartiescurrent": 143435,
    "notesreceivablerelatedpartiescurrent": 696255,
    "prepaidexpensecurrent": 172193,
    "assetscurrent": 123958,
    "propertyplantandequipmentnet": 514834,
    "operatingleaserightofuseasset": 577830,
    "longterminvestments": 1190727,
    "deferredincometaxassetsnet": 1790597,
    "prepaidexpensenoncurrent": 119315,
    "depositsassets": 45519,
    "assets": 11606705,
    "accountspayablecurrent": 23044,
    "shorttermbankloansandnotespayable": 1629000,
    "othershorttermborrowings": 100000,
    "notespayabletobankcurrent": 106800,
    "accruedliabilitiescurrentandnoncurrent": 2118854,
    "customeradvancesforconstruction": 12070,
    "operatingleaseliabilitycurrent": 301105,
    "duetorelatedpartiescurrentandnoncurrent": 288445,
    "notespayablerelatedpartiesclassifiedcurrent": 250000,
    "liabilitiescurrent": 1392756,
    "loanpayable": 124400,
    "securitydepositliability": 19280,
    "operatingleaseliabilitynoncurrent": 297832,
    "convertiblelongtermnotespayable": 2500000,
    "liabilities": 8944638,
    "commonstockvalue": 24420,
    "additionalpaidincapital": 4063320,
    "stockholdersequitynotesubscriptionsreceivable": 3160360,
    "retainedearningsaccumulateddeficit": -25642387,
    "othercomprehensiveincomes": 564860,
    "treasurystockvalue": 9100000,
    "stockholdersequity": -895409,
    "minorityinterest": -776273,
    "stockholdersequityincludingportionattributabletononcontrollinginterest": -3160360,
    "liabilitiesandstockholdersequity": 11606705,
    "preferredstockparorstatedvaluepershare": 0.001,
    "preferredstocksharesauthorized": 20000000,
    "commonstockparorstatedvaluepershare": 0.001,
    "commonstocksharesauthorized": 100000000,
    "commonstocksharesissued": 60000,
    "commonstocksharesoutstanding": 24420526,
    "revenues": 16595,
    "costofrevenue": 18716,
    "grossprofit": -335735,
    "sellinggeneralandadministrativeexpense": 4273468,
    "researchanddevelopmentexpense": 549658,
    "sharebasedcompensation": 4146979,
    "operatingexpenses": 8970105,
    "operatingincomeloss": -8505776,
    "investmentincomeinterest": 71045,
    "interestexpense": 21520,
    "rentalincomenonoperating": 20071,
    "rentalincomerelatedparties": 4800,
    "operatingleaseimpairmentloss": 961217,
    "gainlossoninvestments": -1168733,
    "foreigncurrencytransactiongainlossbeforetax": -3275,
    "equitysecuritiesfvnirealizedgainloss": -1168733,
    "othernonoperatingincomeexpense": 174770,
    "nonoperatingincomeexpense": -2308160,
    "incomelossfromcontinuingoperationsbeforeincometaxesextraordinaryitemsnoncontrollinginterest": -10813936,
    "incometaxexpensebenefit": -220352,
    "netincomeloss": -802420,
    "incomelossfromcontinuingoperationsattributabletononcontrollingentity": -802420,
    "netlossattributabletoabvcandsubsidiaries": -9791164,
    "othercomprehensiveincomelossforeigncurrencytransactionandtranslationadjustmentnetoftax": -98893,
    "comprehensiveincomenetoftax": -9890057,
    "earningspersharebasicanddiluted": -0.5,
    "weightedaveragenumberofshareoutstandingbasicanddiluted": 19715559,
    "depreciation": 37142,
    "allocatedsharebasedcompensationexpense": 4146979,
    "unrealizedgainlossoninvestments": -1168733,
    "othernoncashincomeexpense": 15360,
    "investmentoperatingloss": 1001806,
    "deferredincometaxexpensebenefit": -223201,
    "increasedecreaseinaccountsreceivable": -3696,
    "increasedecreaseinaccountsreceivableandotheroperatingassets": 15778,
    "increasedecreaseduefromotherrelatedparties": 1190755,
    "increasedecreaseinaccountspayabletrade": -951,
    "increasedecreaseinothercurrentliabilities": -359822,
    "increasedecreaseinothernoncurrentliabilities": -1015,
    "increasedecreaseinduetorelatedparties": 501457,
    "netcashprovidedbyusedinoperatingactivities": -5540653,
    "proceedsfromsaleofinvestmentprojects": 147804,
    "paymentsforproceedsfromloansreceivable": -603499,
    "netcashprovidedbyusedininvestingactivities": 751303,
    "proceedsfromissuanceofcommonstock": 7615331,
    "proceedsfromconvertibledebt": 2500000,
    "proceedsfrombankdebt": 650000,
    "proceedsfromothershorttermdebt": 100000,
    "proceedsfromissuanceofotherlongtermdebt": 124400,
    "netproceedsfromshorttermborrowingsfromthirdparties": -408285,
    "proceedsfromrepaymentsofbankoverdrafts": -1013603,
    "netcashprovidedbyusedinfinancingactivities": 9567843,
    "effectofexchangerateoncashandcashequivalents": 62435,
    "cashcashequivalentsrestrictedcashandrestrictedcashequivalentsperiodincreasedecreaseincludingexchangerateeffect": 4840928,
    "cashcashequivalentsrestrictedcashandrestrictedcashequivalents": 5001371,
    "interestpaidnet": 208556,
    "sharesoutstanding": -275347,
    "adjustmentstoadditionalpaidincapitalincapitalcontribution": 7611946,
    "adjustmentstoadditionalpaidincapitalsharescapitalcontribution": 3384615,
    "stockbasedcompensationforoptionsgranted": 1706419,
    "stockissuedduringperiodvaluesharebasedcompensationservices": 902960,
    "stockissuedduringperiodsharebasedcompensationservicesforshares": 641887,
    "stockissuedduringperiodvalueconversionofconvertiblesecurities": 1716136,
    "stockissuedduringperiodsharesconversionofconvertiblesecurities": 915856,
    "cumulativetransactionadjustment": -98893,
    "propertyplantandequipmentestimatedusefullives": "6 years",
    "marketablesecuritiesrealizedgainlossotherthantemporaryimpairmentsamounts": 961217,
    "employeebenefitsandsharebasedcompensation": 1623102,
    "stockbasedcompensationfornonemployees": 2523877,
    "employeebenefitsandsharebasedcompensationnoncash": 13961,
    "percentageofmonthlycontribution": 0.06,
    "duefromrelatedpartiescurrent": 150000,
    "milestonepaymentsroyaltypercentage": 0.12,
    "collaborativeagreementsdescription": "In addition to the total of NT$50 million, approximately equivalent to $1.60 million, BioLite Taiwan is entitled to receive 50% of the future net licensing income or net sales profit. As of December 31, 2020 and 2019, the Company has not earned the royalty under the BHK Collaborative Agreements.",
    "sharesissued": 521887,
    "inventoryfinishedgoods": 100967,
    "inventoryworkinprocess": 22038,
    "inventoryrawmaterialsandsupplies": 61718,
    "allowanceforinventoryvaluationandobsolescenceloss": 184723,
    "propertyplantandequipmentgross": 189760,
    "accumulateddepreciationdepletionandamortizationpropertyplantandequipment": 3298688,
    "equitymethodinvestmentownershippercentage": 0.3162,
    "accountingtreatmentdescription": "Equity Method",
    "relatedpartytransactiondescriptionoftransactions": "Entity controlled by controlling beneficiary shareholder of ABVC",
    "nonmarketablecostmethodinvestmentsnet": 890564,
    "equitymethodinvestments": 268336,
    "assetsnoncurrent": 412342,
    "liabilitiesnoncurrent": 38953,
    "longterminvestmentnetloss": -641636,
    "shareofequitymethodinvesteelosses": -1168733,
    "debtinstrumentconvertiblethresholdpercentageofstockpricetrigger": 0.3162,
    "saleofstockdescriptionoftransaction": "The Company sold 218,000 shares of common stock of BioHopeKing Corporation at price of NT$24, equivalent $0.85, to several individuals, and the percentage of ownership decreased to 5.90% as of December 31, 2020. As a result of the transactions, the Company recognized investment loss of $40,589 and impairment loss of $961,217 for the same period.",
    "debtinstrumentfaceamount": 1000000,
    "convertibledebt": 2750000,
    "debtinstrumentincreaseaccruedinterest": 306667,
    "totalinterestexpenses": 240420,
    "shorttermborrowings": 650000,
    "debtinstrumentinterestrateeffectivepercentage": 0.021,
    "interestanddebtexpense": 53992,
    "loanspayable": 750000,
    "interestexpenseother": 12204,
    "othernotespayable": 106800,
    "interestreceivable": 1302,
    "accountsreceivablerelatedparties": 1210,
    "duetorelatedpartiescurrent": 72704,
    "shorttermdebtaverageoutstandingamount": 1610,
    "accruedinterest": 166261,
    "debtinstrumentinterestrateterms": "The advances bear 0% interest rate and are due on demand.",
    "aggregateworkingcapital": 9205,
    "relatedpartytransactionrate": 0.12,
    "outstandingadvancefromrelatedparty": 675,
    "duefromotherrelatedparties": 123583,
    "debtinstrumentconvertibleconversionprice1": 2.9,
    "advancesbearinterestdescription": "The Company had advances from one employee for working capital purpose. The outstanding balance due to this employee amounted to $72,704 as of December 31, 2020. This loan bears interest rate of 1.5% per annum, and is due on demand.",
    "outstandingservicescharge": 52000,
    "professionalfees": 135000,
    "proceedsfromcontributionsfromaffiliates": 7615331,
    "sharesissuedpricepershare": 3.68,
    "numberofinvestors": 45,
    "unrestrictedcommonshares": 50000,
    "sharebasedcompensationarrangementbysharebasedpaymentawardfairvalueassumptionsriskfreeinterestrate": 0.0038,
    "sharebasedcompensationarrangementbysharebasedpaymentawardfairvalueassumptionsexpectedterm1": "P5Y0M0D",
    "sharebasedcompensationarrangementbysharebasedpaymentawardfairvalueassumptionsexpectedvolatilityrate": 0.8901,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsoutstandingnumber": 545182,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsgrantsinperiod": 545182,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsexercisablenumber": 545182,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsvestedandexpectedtovestoutstandingnumber": 545182,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsoutstandingweightedaverageexerciseprice": 2,
    "sharebasedcompensationarrangementsbysharebasedpaymentawardoptionsgrantsinperiodweightedaverageexerciseprice": 2,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsexercisableweightedaverageexerciseprice": 2,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsvestedandexpectedtovestoutstandingweightedaverageexerciseprice": 2,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsgrantweightedaverageremainingcontractualterm": "P9Y10M21D",
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsoutstandingweightedaverageremainingcontractualterm2": "P9Y10M21D",
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsexercisableweightedaverageremainingcontractualterm1": "P9Y10M21D",
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsvestedandexpectedtovestoutstandingweightedaverageremainingcontractualterm1": "P9Y10M21D",
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsgrantinperiodgrantdateintrinsicvalue": 616056,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsoutstandingintrinsicvalue": 616056,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsexercisableintrinsicvalue1": 616056,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsvestedandexpectedtovestexercisableaggregateintrinsicvalue": 616056,
    "classofwarrantorrightexercisepriceofwarrantsorrights1": 2,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsvestedandexpectedtovestexercisableweightedaverageremainingcontractualterm1": "P10Y",
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsgrantsinperiodweightedaveragegrantdatefairvalue": 3.13,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsgrants": 1706419,
    "sharebasedcompensationarrangementbysharebasedpaymentawardnumberofsharesavailableforgrant": 2812949,
    "netloss": -9791164,
    "weightedaveragenumberofsharesoutstandingbasic": 19715559,
    "weightedaveragenumberofdilutedsharesoutstanding": 19715559,
    "earningspersharebasic": -0.5,
    "earningspersharediluted": -0.5,
    "operatingleasecost": 337282,
    "operatingleaseleaseincomeleasepayments": 337282,
    "operatingleaseweightedaverageremainingleaseterm1": "P3Y0M29D",
    "operatingleaseweightedaveragediscountratepercent": 0.0055,
    "operatingleasesfutureminimumpaymentsduecurrent": 324788,
    "operatingleasesfutureminimumpaymentsdueintwoyears": 341527,
    "operatingleasesfutureminimumpaymentsdueinthreeyears": 358431,
    "operatingleasesfutureminimumpaymentsdueinfouryears": 375337,
    "operatingleasesfutureminimumpaymentsdueinfiveyears": 338676,
    "operatingleasesfutureminimumpaymentsduethereafter": 56916,
    "operatingleasesfutureminimumpaymentsdue": 1795675,
    "interestportionofminimumleasepaymentssaleleasebacktransactions": 22930,
    "presentvalueoffutureminimumleasepaymentssaleleasebacktransactions": 1772745,
    "operatingleaseliability": 598937,
    "cumulativeeffectadjustmentofopeningbalanceofaccumulateddeficit": -21107
  },
  {
    "date": "2019-12-30",
    "symbol": "ABVC",
    "period": "FY",
    "entityregistrantname": "American BriVision (Holding) Corp",
    "entitycentralindexkey": 1173313,
    "amendmentflag": "false",
    "currentfiscalyearenddate": "--12-31",
    "documenttype": "10-K",
    "documentperiodenddate": "2019-12-31",
    "documentfiscalperiodfocus": "FY",
    "documentfiscalyearfocus": 2019,
    "entityfilercategory": "Non-accelerated Filer",
    "entitysmallbusiness": "true",
    "entityshellcompany": "false",
    "entitycurrentreportingstatus": "Yes",
    "entityemerginggrowthcompany": "false",
    "entityfilenumber": "333-91436",
    "entityinteractivedatacurrent": "Yes",
    "entityincorporationstatecountrycode": "NV",
    "entitywellknownseasonedissuer": "No",
    "entityvoluntaryfilers": "No",
    "cashandcashequivalentsatcarryingvalue": 144295,
    "restrictedcashandcashequivalents": 16148,
    "accountsreceivablenet": 163566,
    "accountsreceivablerelatedparties": 142225,
    "notesreceivablerelatedpartiescurrent": 333682,
    "prepaidexpensecurrent": 77269,
    "assetscurrent": 82254,
    "propertyplantandequipmentnet": 520930,
    "operatingleaserightofuseasset": 577830,
    "longterminvestments": 3364619,
    "deferredtaxassetsliabilitiesnetnoncurrent": 1460033,
    "prepaidexpensenoncurrent": 135443,
    "depositsassets": 44103,
    "assets": 6927811,
    "accountspayablecurrent": 23995,
    "shorttermbankloansandnotespayable": 1918500,
    "loanspayabletobankcurrent": 13403,
    "notespayablecurrent": 100200,
    "accruedliabilitiescurrentandnoncurrent": 2007573,
    "customeradvancesforconstruction": 13085,
    "operatingleaseliabilitycurrent": 301105,
    "duetorelatedpartiescurrentandnoncurrent": 100000000,
    "convertiblenotespayablecurrent": 820000,
    "notespayablerelatedpartiesclassifiedcurrent": 1187500,
    "liabilitiescurrent": 312950,
    "securitydepositliability": 2880,
    "operatingleaseliabilitynoncurrent": 297832,
    "liabilities": 7052628,
    "commonstockvalue": 19478,
    "additionalpaidincapital": 28180348,
    "stockholdersequitynotesubscriptionsreceivable": 4063320,
    "retainedearningsaccumulateddeficit": -15851223,
    "othercomprehensiveincomes": 663753,
    "treasurystockvalue": 9100000,
    "stockholdersequity": -167928,
    "minorityinterest": 26147,
    "stockholdersequityincludingportionattributabletononcontrollinginterest": -4063320,
    "liabilitiesandstockholdersequity": 6927811,
    "preferredstockparorstatedvaluepershare": 0.001,
    "preferredstocksharesauthorized": 20000000,
    "commonstockparorstatedvaluepershare": 0.001,
    "commonstocksharesauthorized": 20000000,
    "commonstocksharesissued": 19478168,
    "commonstocksharesoutstanding": 19478168,
    "revenues": 43975,
    "costofrevenue": 20137,
    "grossprofit": -37160,
    "sellinggeneralandadministrativeexpense": 3069493,
    "researchanddevelopmentexpense": 1048553,
    "sharebasedcompensation": 22314,
    "operatingexpenses": 4140360,
    "operatingincomeloss": -3458778,
    "investmentincomeinterest": 23344,
    "interestexpense": 482014,
    "rentalincomenonoperating": 19487,
    "rentalincomerelatedparties": 4400,
    "gainlossoninvestments": -210086,
    "foreigncurrencytransactiongainlossbeforetax": 407,
    "equitysecuritiesfvnirealizedgainloss": -210086,
    "othernonoperatingincomeexpense": 92959,
    "nonoperatingincomeexpense": -551503,
    "incomelossfromcontinuingoperationsbeforeincometaxesextraordinaryitemsnoncontrollinginterest": -4010281,
    "incometaxexpensebenefit": -77041,
    "netincomeloss": -3641776,
    "incomelossfromcontinuingoperationsattributabletononcontrollingentity": -291464,
    "netlossattributabletoabvcandsubsidiaries": -3641776,
    "othercomprehensiveincomelossforeigncurrencytransactionandtranslationadjustmentnetoftax": 7902,
    "comprehensiveincomenetoftax": -3633874,
    "earningspersharebasicanddiluted": -0.21,
    "weightedaveragenumberofshareoutstandingbasicanddiluted": 17498543,
    "sharesoutstanding": -275347,
    "stockissuedduringperiodvaluenewissues": -4063320,
    "stockissuedduringperiodsharesnewissues": 428571,
    "stockissuedduringperiodvaluesharebasedcompensation": 22314,
    "profitloss": -291463,
    "cumulativetransactionadjustments": 7902,
    "depreciation": 55086,
    "allocatedsharebasedcompensationexpense": 22314,
    "lossoninvestmentinequitysecurities": 210086,
    "othernoncashincomeandexpenses": -5747,
    "deferredincometaxexpensebenefit": -80692,
    "increasedecreaseinaccountsreceivable": 120739,
    "increasedecreaseinaccountsreceivableandotheroperatingassets": 27617,
    "increasedecreaseduefromotherrelatedparties": 282092,
    "increasedecreaseininventories": -1306,
    "increasedecreaseinaccountspayable": 50244,
    "increasedecreaseinnotespayablecurrent": -4861,
    "increasedecreaseinothercurrentliabilities": 801434,
    "increasedecreaseinadvancefromothers": -1909,
    "increasedecreaseinduetorelatedparties": 178083,
    "netcashprovidedbyusedinoperatingactivities": -3134526,
    "paymentstoacquireloansreceivable": 17496,
    "paymentstoacquireinvestments": 17801,
    "netcashprovidedbyusedininvestingactivities": -35297,
    "proceedsfromissuanceofcommonstock": 531147,
    "issuanceofcommonsharesforstockbasedcompensation": 552962,
    "proceedsfrombankdebt": 1000000,
    "proceedsfromconvertibledebt": 1207500,
    "proceedsfromothershorttermdebt": 657466,
    "repaymentsofrelatedpartydebt": 820000,
    "repaymentsofbankdebt": 41586,
    "netcashprovidedbyusedinfinancingactivities": 3087489,
    "effectofexchangerateoncashandcashequivalents": -4,
    "cashandcashequivalentsperiodincreasedecrease": -82338,
    "cashcashequivalentsrestrictedcashandrestrictedcashequivalents": 160443,
    "incometaxespaid": 167126,
    "interestpaidnet": 2050,
    "commonsharesissuedforemployeesandconsultants": 325740,
    "capitalcontributionfromrelatedparties": 7872340,
    "equitymethodinvestmentownershippercentage": 0.3161,
    "propertyplantandequipmentestimatedusefullives": "6 years",
    "stockbasedcompensationfornonemployees": 22314,
    "accruedemployeebenefitscurrent": 15928,
    "partnerscapitalaccountcontributions": 1602040,
    "salarieswagesandofficerscompensation": 920000,
    "accruedsalariescurrent": 645000,
    "principalandaccruedinterest": 1456780,
    "loansandleasesreceivablerelatedparties": 367000,
    "duefromrelatedpartiescurrent": 675,
    "milestonepaymentsroyaltypercentage": 0.12,
    "collaborativeagreementsdescription": "In addition to the total of NT$50 million, approximately equivalent to $1.60 million, BioLite Taiwan is entitled to receive 50% of the future net licensing income or net sales profit. As of December 31, 2019 and 2018, the Company has not earned the royalty under the BHK Collaborative Agreements.",
    "inventoryfinishedgoods": 94727,
    "inventoryworkinprocess": 20676,
    "inventoryrawmaterialsandsupplies": 57904,
    "allowanceforinventoryvaluationandobsolescenceloss": 173307,
    "propertyplantandequipmentgross": 178409,
    "accumulateddepreciationdepletionandamortizationpropertyplantandequipment": 3241294,
    "accountingtreatmentdescription": "Equity Method",
    "relatedpartytransactiondescriptionoftransactions": "Mr. George Lee, the Director and Chairman of Biokey, is the Chairman of GenePharm.",
    "nonmarketablecostmethodinvestmentsnet": 1998310,
    "equitymethodinvestments": 1336449,
    "assetsnoncurrent": 62768,
    "liabilitiesnoncurrent": 78888,
    "shareofequitymethodinvesteelosses": -210086,
    "incomelossfromequitymethodinvestments": -210086,
    "debtinstrumentconvertiblethresholdpercentageofstockpricetrigger": 0.3163,
    "debtinstrumentfaceamount": 8900000,
    "convertibledebt": 2007500,
    "debtinstrumentincreaseaccruedinterest": 181852,
    "totalinterestexpenses": 145514,
    "shorttermborrowings": 1000000,
    "longtermdebt": 13403,
    "longtermdebtcurrent": 13403,
    "debtinstrumentmaturitydate": "2017-04-30",
    "debtinstrumentterm": "P7Y",
    "debtinstrumentinterestrateeffectivepercentage": 0.0224,
    "interestanddebtexpense": 10563,
    "interestexpenseother": 11778,
    "duetorelatedpartiescurrent": 284479,
    "aggregateworkingcapital": 9205,
    "debtinstrumentinterestrateterms": "The development costs shall be shared 50/50 between BHK and the Company. The BHK Co-Development Agreement will remain in effect for fifteen years from the date of first commercial sale of the Product in in Asia excluding Japan.",
    "accruedinterest": 255,
    "relatedpartytransactionrate": 0.12,
    "shorttermdebtaverageoutstandingamount": 40000,
    "outstandingadvancefromrelatedparty": 12000,
    "duefromotherrelatedparties": 115946,
    "advancesbearinterestdescription": "Company entered into several agreements with our shareholders. The advances bear interest from 12% to 13.6224% per annum.",
    "stockissuedvalue": 3000000,
    "weightedaveragenumberofsharesoutstandingbasic": 17498543,
    "weightedaveragenumberofdilutedsharesoutstanding": 17498543,
    "earningspersharebasic": -0.21,
    "earningspersharediluted": -0.21,
    "operatingleaseleaseincomeleasepayments": 301437,
    "operatingleaseweightedaverageremainingleaseterm1": "P3Y0M29D",
    "operatingleaseweightedaveragediscountratepercent": 0.0055,
    "operatingleasesfutureminimumpaymentsduecurrent": 309330,
    "operatingleasesfutureminimumpaymentsdueintwoyears": 92614,
    "operatingleasesfutureminimumpaymentsdueinthreeyears": 50307,
    "operatingleasesfutureminimumpaymentsdueinfouryears": 50307,
    "operatingleasesfutureminimumpaymentsdueinfiveyears": 50307,
    "operatingleasesfutureminimumpaymentsdue": 552865,
    "interestportionofminimumleasepaymentssaleleasebacktransactions": 13062,
    "presentvalueoffutureminimumleasepaymentssaleleasebacktransactions": 539803,
    "operatingleaseliability": 598937,
    "cumulativeeffectadjustmentofopeningbalanceofaccumulateddeficit": -21107
  }
]